The U.S. Justice Department dumped its lawsuit accusing UnitedHealth Group and affiliated health plans of exaggerating how sick its patients were to score millions of dollars in inflated Medicare Advantage payments.
Former Cleveland Clinic Innovations executive director Gary Fingerhut has pleaded guilty to two charges related to a scheme that allegedly cost the clinic more than $2.7 million.
A lawsuit about to go to trial in Canada seeking to allow the sale of private plans raises questions about the growing Democratic push to adopt the Canadian-style single-payer model in the U.S.
A federal judge tossed the Department of Justice's suit claiming UnitedHealth Group scored millions in inflated Medicare Advantage payments, striking a blow against the feds' latest attempt to fight medical upcoding and alleged fraud.
Nearly 300 healthcare institutions in 41 states have developed similar partnerships to guide families and pediatric patient caregivers on legal issues beyond the scope of clinical care that affect children's health.
A CVS customer wants to end a federal lawsuit that hit the drugstore chain in a sensitive area: The prices it charges for prescriptions.
The suit, which seeks class action status, could represent up to 12,000 Aetna customers in at least 23 states who received mail from the insurer revealing their HIV status.
CliniComp, an EHR vendor that supplies software to the VA and Defense Department, says it might have been considered for the contract had the VA conducted open and competitive bidding.
Cincinnati and South Carolina are the latest to sue drug distributors and manufacturers for allegedly fueling the opioid crisis by filling suspicious drug orders. Companies call the efforts "misguided."
In a 2-1 ruling, a federal appeals court panel ruled that Arkansas can block Medicaid funding to Planned Parenthood, two years after the state ended its contract with the group over videos secretly recorded by an anti-abortion group.
California hospitals could claw back hundreds of millions of dollars in Medicaid payments after a federal appeals court ruled HHS didn't have appropriate evidence to approve the state's outpatient care pay cuts.
Martin Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted on federal charges he deceived investors in a pair of failed hedge funds.